| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
3 companies
Commodore Capital LP is a 10% Owner at Vera Therapeutics, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 5 buys and 1 sell.
Estimated insider holdings value: $189.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2024 | VERA Vera Therapeutics, Inc. | 10% Owner | Sell | 1,050,000 | $18.00 | $18,900,000.00 | -19.3% | +97.6% | +92.9% | |
| Aug 7, 2023 | VTGN Vistagen Therapeutics, Inc. | 10% Owner | Buy | 775,756 | $23.15 | $17,961,078.67 | +97.1% | -74.0% | -75.5% | |
| Jun 20, 2023 | VERA Vera Therapeutics, Inc. | 10% Owner | Buy | 448,217 | $15.17 | $6,799,003.67 | +9.0% | +10.9% | +136.9% | |
| Feb 23, 2023 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 622 | $22.07 | $13,723.27 | - | -22.0% | -34.6% | |
| Feb 22, 2023 | ELVN Enliven Therapeutics, Inc. | 10% Owner | Buy | 31,759 | $5.15 | $163,498.15 | +0.6% | -10.0% | -27.1% |